APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liposomes and Lipid Nanoparticles Pharmaceutical Reagents

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Analysis and Forecast 2026-2032

24 December 2025216 pages

Choose your research edition.

Industry ResearchLiposomes and Lipid Nanoparticles Pharmaceutical Reagents Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Liposomes and Lipid Nanoparticles Pharmaceutical Reagents's global sales reached XX (units) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned Evonik as the global sales leader, a title it has maintained for several consecutive years. Notably, Evonik's performance in primary markets is also remarkable. In the Chinese market, sales were XX (units), a change of XX% from the previous year. In Europe, sales were XX (units), showing a year-on-year of XX%. In the US, sales were XX (units), a year-on-year change of XX%.

The major global manufacturers in the Liposomes and Lipid Nanoparticles Pharmaceutical Reagents market include Evonik, MicroNano Biologics, GenScript, WuXi STA, Wacker, Precigenome, Polymun Scientific, Nippon Fine Chemical and Merck KGaA, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the Liposomes and Lipid Nanoparticles Pharmaceutical Reagents production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of Liposomes and Lipid Nanoparticles Pharmaceutical Reagents by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for Liposomes and Lipid Nanoparticles Pharmaceutical Reagents, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Liposomes and Lipid Nanoparticles Pharmaceutical Reagents, also provides the consumption of main regions and countries. Of the upcoming market potential for Liposomes and Lipid Nanoparticles Pharmaceutical Reagents, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Liposomes and Lipid Nanoparticles Pharmaceutical Reagents sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Liposomes and Lipid Nanoparticles Pharmaceutical Reagents sales, projected growth trends, production technology, application and end-user industry.

Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Segment by Company

Evonik

MicroNano Biologics

GenScript

WuXi STA

Wacker

Precigenome

Polymun Scientific

Nippon Fine Chemical

Merck KGaA

Genevant Sciences

Cytiva

Croda International

Creative Biolabs

Corden Pharma

Catalent

Acuitas Therapeutics

Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Segment by Type

Small Molecule/Peptide Delivery Lipids

siRNA-Delivery Lipids

mRNA-Delivery Lipids

Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Segment by Application

Vaccine

Gene Therapy

Cancer Treatment

Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liposomes and Lipid Nanoparticles Pharmaceutical Reagents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liposomes and Lipid Nanoparticles Pharmaceutical Reagents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Liposomes and Lipid Nanoparticles Pharmaceutical Reagents production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Liposomes and Lipid Nanoparticles Pharmaceutical Reagents in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Liposomes and Lipid Nanoparticles Pharmaceutical Reagents manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liposomes and Lipid Nanoparticles Pharmaceutical Reagents sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Small Molecule/Peptide Delivery Lipids Major Manufacturers Table 3. siRNA-Delivery Lipids Major Manufacturers Table 4. mRNA-Delivery Lipids Major Manufacturers Table 5. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Vaccine Major Manufacturers Table 7. Gene Therapy Major Manufacturers Table 8. Cancer Treatment Major Manufacturers Table 9. Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Industry Trends Table 10. Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Industry Drivers Table 11. Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Industry Opportunities and Challenges Table 12. Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Industry Restraints Table 13. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (units) Table 14. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Production by Region (2021-2026) & (units) Table 15. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Production by Region (2027-2032) & (units) Table 16. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Production Market Share by Region (2021-2026) Table 17. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Production Market Share by Region (2027-2032) Table 18. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Market Share by Region (2021-2026) Table 22. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Market Share by Region (2027-2032) Table 23. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (units) Table 24. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Region (2021-2026) & (units) Table 25. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Region (2027-2032) & (units) Table 26. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share by Region (2021-2026) Table 27. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share by Region (2027-2032) Table 28. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share by Manufacturers (2021-2026) Table 32. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price (USD/unit) of Manufacturers (2021-2026) Table 33. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Manufacturers, Product Type & Application Table 36. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Manufacturers Commercialization Time Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 39. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Market Share by Type (2021-2026) Table 42. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Market Share by Type (2027-2032) Table 43. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2021-2026) & (units) Table 44. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2027-2032) & (units) Table 45. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share by Type (2021-2026) Table 46. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share by Type (2027-2032) Table 47. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Price by Type (2021-2026) & (USD/unit) Table 48. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Price by Type (2027-2032) & (USD/unit) Table 49. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Market Share by Application (2021-2026) Table 52. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Market Share by Application (2027-2032) Table 53. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2021-2026) & (units) Table 54. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2027-2032) & (units) Table 55. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share by Application (2021-2026) Table 56. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share by Application (2027-2032) Table 57. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Price by Application (2021-2026) & (USD/unit) Table 58. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Price by Application (2027-2032) & (USD/unit) Table 59. Evonik Company Information Table 60. Evonik Business Overview Table 61. Evonik Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 62. Evonik Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 63. Evonik Recent Development Table 64. MicroNano Biologics Company Information Table 65. MicroNano Biologics Business Overview Table 66. MicroNano Biologics Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 67. MicroNano Biologics Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 68. MicroNano Biologics Recent Development Table 69. GenScript Company Information Table 70. GenScript Business Overview Table 71. GenScript Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 72. GenScript Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 73. GenScript Recent Development Table 74. WuXi STA Company Information Table 75. WuXi STA Business Overview Table 76. WuXi STA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. WuXi STA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 78. WuXi STA Recent Development Table 79. Wacker Company Information Table 80. Wacker Business Overview Table 81. Wacker Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. Wacker Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 83. Wacker Recent Development Table 84. Precigenome Company Information Table 85. Precigenome Business Overview Table 86. Precigenome Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Precigenome Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 88. Precigenome Recent Development Table 89. Polymun Scientific Company Information Table 90. Polymun Scientific Business Overview Table 91. Polymun Scientific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Polymun Scientific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 93. Polymun Scientific Recent Development Table 94. Nippon Fine Chemical Company Information Table 95. Nippon Fine Chemical Business Overview Table 96. Nippon Fine Chemical Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Nippon Fine Chemical Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 98. Nippon Fine Chemical Recent Development Table 99. Merck KGaA Company Information Table 100. Merck KGaA Business Overview Table 101. Merck KGaA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Merck KGaA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 103. Merck KGaA Recent Development Table 104. Genevant Sciences Company Information Table 105. Genevant Sciences Business Overview Table 106. Genevant Sciences Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Genevant Sciences Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 108. Genevant Sciences Recent Development Table 109. Cytiva Company Information Table 110. Cytiva Business Overview Table 111. Cytiva Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Cytiva Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 113. Cytiva Recent Development Table 114. Croda International Company Information Table 115. Croda International Business Overview Table 116. Croda International Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Croda International Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 118. Croda International Recent Development Table 119. Creative Biolabs Company Information Table 120. Creative Biolabs Business Overview Table 121. Creative Biolabs Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Creative Biolabs Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 123. Creative Biolabs Recent Development Table 124. Corden Pharma Company Information Table 125. Corden Pharma Business Overview Table 126. Corden Pharma Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Corden Pharma Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 128. Corden Pharma Recent Development Table 129. Catalent Company Information Table 130. Catalent Business Overview Table 131. Catalent Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. Catalent Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 133. Catalent Recent Development Table 134. Acuitas Therapeutics Company Information Table 135. Acuitas Therapeutics Business Overview Table 136. Acuitas Therapeutics Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. Acuitas Therapeutics Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio Table 138. Acuitas Therapeutics Recent Development Table 139. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Type (2021-2026) & (US$ Million) Table 140. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Type (2027-2032) & (US$ Million) Table 141. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2021-2026) & (units) Table 142. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2027-2032) & (units) Table 143. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Type (2021-2026) & (USD/unit) Table 144. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Type (2027-2032) & (USD/unit) Table 145. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Application (2021-2026) & (US$ Million) Table 146. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Application (2027-2032) & (US$ Million) Table 147. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2021-2026) & (units) Table 148. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2027-2032) & (units) Table 149. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Application (2021-2026) & (USD/unit) Table 150. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Application (2027-2032) & (USD/unit) Table 151. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 153. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 154. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country (2021 VS 2025 VS 2032) & (units) Table 155. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country (2021-2026) & (units) Table 156. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country (2027-2032) & (units) Table 157. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Country (2021-2026) & (USD/unit) Table 158. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Country (2027-2032) & (USD/unit) Table 159. United States Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 160. Canada Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 161. Mexico Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 162. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Type (2021-2026) & (US$ Million) Table 163. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Type (2027-2032) & (US$ Million) Table 164. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2021-2026) & (units) Table 165. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2027-2032) & (units) Table 166. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Type (2021-2026) & (USD/unit) Table 167. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Type (2027-2032) & (USD/unit) Table 168. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Application (2021-2026) & (US$ Million) Table 169. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Application (2027-2032) & (US$ Million) Table 170. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2021-2026) & (units) Table 171. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2027-2032) & (units) Table 172. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Application (2021-2026) & (USD/unit) Table 173. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Application (2027-2032) & (USD/unit) Table 174. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 176. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 177. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country (2021 VS 2025 VS 2032) & (units) Table 178. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country (2021-2026) & (units) Table 179. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country (2027-2032) & (units) Table 180. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Country (2021-2026) & (USD/unit) Table 181. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Country (2027-2032) & (USD/unit) Table 182. Germany Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 183. France Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 184. U.K. Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 185. Italy Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 186. Russia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 187. Spain Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 188. Netherlands Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 189. Switzerland Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 190. Sweden Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 191. Poland Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 192. China Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Type (2021-2026) & (US$ Million) Table 193. China Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Type (2027-2032) & (US$ Million) Table 194. China Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2021-2026) & (units) Table 195. China Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2027-2032) & (units) Table 196. China Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Type (2021-2026) & (USD/unit) Table 197. China Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Type (2027-2032) & (USD/unit) Table 198. China Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Application (2021-2026) & (US$ Million) Table 199. China Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Application (2027-2032) & (US$ Million) Table 200. China Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2021-2026) & (units) Table 201. China Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2027-2032) & (units) Table 202. China Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Application (2021-2026) & (USD/unit) Table 203. China Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Application (2027-2032) & (USD/unit) Table 204. Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Type (2021-2026) & (US$ Million) Table 205. Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Type (2027-2032) & (US$ Million) Table 206. Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2021-2026) & (units) Table 207. Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2027-2032) & (units) Table 208. Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Type (2021-2026) & (USD/unit) Table 209. Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Type (2027-2032) & (USD/unit) Table 210. Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Application (2021-2026) & (US$ Million) Table 211. Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Application (2027-2032) & (US$ Million) Table 212. Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2021-2026) & (units) Table 213. Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2027-2032) & (units) Table 214. Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Application (2021-2026) & (USD/unit) Table 215. Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Application (2027-2032) & (USD/unit) Table 216. Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 217. Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 218. Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 219. Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country (2021 VS 2025 VS 2032) & (units) Table 220. Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country (2021-2026) & (units) Table 221. Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country (2027-2032) & (units) Table 222. Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Country (2021-2026) & (USD/unit) Table 223. Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Country (2027-2032) & (USD/unit) Table 224. Japan Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 225. South Korea Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 226. India Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 227. Australia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 228. Taiwan Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 229. Southeast Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 230. SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Type (2021-2026) & (US$ Million) Table 231. SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Type (2027-2032) & (US$ Million) Table 232. SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2021-2026) & (units) Table 233. SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2027-2032) & (units) Table 234. SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Type (2021-2026) & (USD/unit) Table 235. SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Type (2027-2032) & (USD/unit) Table 236. SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Application (2021-2026) & (US$ Million) Table 237. SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Application (2027-2032) & (US$ Million) Table 238. SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2021-2026) & (units) Table 239. SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2027-2032) & (units) Table 240. SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Application (2021-2026) & (USD/unit) Table 241. SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Application (2027-2032) & (USD/unit) Table 242. SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 243. SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 244. SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 245. SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country (2021 VS 2025 VS 2032) & (units) Table 246. SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country (2021-2026) & (units) Table 247. SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country (2027-2032) & (units) Table 248. SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Country (2021-2026) & (USD/unit) Table 249. SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Country (2027-2032) & (USD/unit) Table 250. Brazil Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 251. Argentina Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 252. Chile Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 253. Colombia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 254. Peru Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 255. Saudi Arabia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 256. Israel Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 257. UAE Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 258. Turkey Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 259. Iran Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 260. Egypt Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Table 261. Key Raw Materials Table 262. Raw Materials Key Suppliers Table 263. Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Distributors List Table 264. Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Customers List Table 265. Research Programs/Design for This Report Table 266. Authors List of This Report Table 267. Secondary Sources Table 268. Primary Sources List of Figures Figure 1. Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Image Figure 2. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Share 2021 VS 2025 VS 2032 Figure . Small Molecule/Peptide Delivery Lipids Image Figure 1. siRNA-Delivery Lipids Image Figure 2. mRNA-Delivery Lipids Image Figure 3. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size Share 2021 VS 2025 VS 2032 Figure 5. Vaccine Image Figure 6. Gene Therapy Image Figure 7. Cancer Treatment Image Figure 8. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Capacity, Capacity Utilization (2021-2032) & (units) Figure 9. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Production by Region: 2021 VS 2025 VS 2032 (units) Figure 10. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Production Market Share by Region: 2025 Versus 2032 Figure 11. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Production Market Share by Region (2021-2032) Figure 12. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Production Growth Rate (2021-2032) & (units) Figure 13. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Production Growth Rate (2021-2032) & (units) Figure 14. China Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Production Growth Rate (2021-2032) & (units) Figure 15. Japan Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Production Growth Rate (2021-2032) & (units) Figure 16. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (2021-2032) & (US$ Million) Figure 18. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Market Share by Region (2021-2032) Figure 21. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales (2021-2032) & (units) Figure 22. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Region: 2021 VS 2025 VS 2032 (units) Figure 23. Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share by Region (2021-2032) Figure 24. North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales YoY (2021-2032) & (units) Figure 25. Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales YoY (2021-2032) & (units) Figure 26. China Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales YoY (2021-2032) & (units) Figure 27. Asia (Excluding China) Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales YoY (2021-2032) & (units

Scope & coverage.

Types
  • Small Molecule/Peptide Delivery Lipids
  • siRNA-Delivery Lipids
  • mRNA-Delivery Lipids
Applications
  • Vaccine
  • Gene Therapy
  • Cancer Treatment
Companies covered
  • Evonik
  • MicroNano Biologics
  • GenScript
  • WuXi STA
  • Wacker
  • Precigenome
  • Polymun Scientific
  • Nippon Fine Chemical
  • Merck KGaA
  • Genevant Sciences
  • Cytiva
  • Croda International
  • Creative Biolabs
  • Corden Pharma
  • Catalent
  • Acuitas Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market by Type
  3. 1.2.1 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Small Molecule/Peptide Delivery Lipids
  5. 1.2.3 siRNA-Delivery Lipids
  6. 1.2.4 mRNA-Delivery Lipids
  7. 1.3 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market by Application
  8. 1.3.1 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Vaccine
  10. 1.3.3 Gene Therapy
  11. 1.3.4 Cancer Treatment
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Dynamics
  1. 2.1 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Industry Trends
  2. 2.2 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Industry Drivers
  3. 2.3 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Industry Opportunities and Challenges
  4. 2.4 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Industry Restraints
3 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Production Overview
  1. 3.1 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Production Capacity (2021-2032)
  2. 3.2 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Production by Region
  4. 3.3.1 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Production by Region (2021-2026)
  5. 3.3.2 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Production by Region (2027-2032)
  6. 3.3.3 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Region
  3. 4.2.1 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Region (2021-2026)
  5. 4.2.3 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Region (2027-2032)
  6. 4.2.4 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Region
  9. 4.4.1 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Region (2021-2026)
  11. 4.4.3 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Region (2027-2032)
  12. 4.4.4 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Manufacturers
  2. 5.1.1 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Manufacturers
  6. 5.2.1 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Manufacturers, Product Type & Application
  13. 5.7 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market CR5 and HHI
  16. 5.8.2 2025 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Tier 1, Tier 2, and Tier 3
6 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market by Type
  1. 6.1 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Type
  2. 6.1.1 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type
  5. 6.2.1 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2021-2032) & (units)
  6. 6.2.2 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share by Type (2021-2032)
  7. 6.3 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Price by Type
7 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market by Application
  1. 7.1 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Application
  2. 7.1.1 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application
  5. 7.2.1 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2021-2032) & (units)
  6. 7.2.2 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Market Share by Application (2021-2032)
  7. 7.3 Global Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Price by Application
8 Company Profiles
  1. 8.1 Evonik
  2. 8.1.1 Evonik Company Information
  3. 8.1.2 Evonik Business Overview
  4. 8.1.3 Evonik Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 Evonik Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  6. 8.1.5 Evonik Recent Developments
  7. 8.2 MicroNano Biologics
  8. 8.2.1 MicroNano Biologics Company Information
  9. 8.2.2 MicroNano Biologics Business Overview
  10. 8.2.3 MicroNano Biologics Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 MicroNano Biologics Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  12. 8.2.5 MicroNano Biologics Recent Developments
  13. 8.3 GenScript
  14. 8.3.1 GenScript Company Information
  15. 8.3.2 GenScript Business Overview
  16. 8.3.3 GenScript Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 GenScript Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  18. 8.3.5 GenScript Recent Developments
  19. 8.4 WuXi STA
  20. 8.4.1 WuXi STA Company Information
  21. 8.4.2 WuXi STA Business Overview
  22. 8.4.3 WuXi STA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 WuXi STA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  24. 8.4.5 WuXi STA Recent Developments
  25. 8.5 Wacker
  26. 8.5.1 Wacker Company Information
  27. 8.5.2 Wacker Business Overview
  28. 8.5.3 Wacker Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 Wacker Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  30. 8.5.5 Wacker Recent Developments
  31. 8.6 Precigenome
  32. 8.6.1 Precigenome Company Information
  33. 8.6.2 Precigenome Business Overview
  34. 8.6.3 Precigenome Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 8.6.4 Precigenome Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  36. 8.6.5 Precigenome Recent Developments
  37. 8.7 Polymun Scientific
  38. 8.7.1 Polymun Scientific Company Information
  39. 8.7.2 Polymun Scientific Business Overview
  40. 8.7.3 Polymun Scientific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 8.7.4 Polymun Scientific Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  42. 8.7.5 Polymun Scientific Recent Developments
  43. 8.8 Nippon Fine Chemical
  44. 8.8.1 Nippon Fine Chemical Company Information
  45. 8.8.2 Nippon Fine Chemical Business Overview
  46. 8.8.3 Nippon Fine Chemical Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 8.8.4 Nippon Fine Chemical Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  48. 8.8.5 Nippon Fine Chemical Recent Developments
  49. 8.9 Merck KGaA
  50. 8.9.1 Merck KGaA Company Information
  51. 8.9.2 Merck KGaA Business Overview
  52. 8.9.3 Merck KGaA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 8.9.4 Merck KGaA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  54. 8.9.5 Merck KGaA Recent Developments
  55. 8.10 Genevant Sciences
  56. 8.10.1 Genevant Sciences Company Information
  57. 8.10.2 Genevant Sciences Business Overview
  58. 8.10.3 Genevant Sciences Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 8.10.4 Genevant Sciences Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  60. 8.10.5 Genevant Sciences Recent Developments
  61. 8.11 Cytiva
  62. 8.11.1 Cytiva Company Information
  63. 8.11.2 Cytiva Business Overview
  64. 8.11.3 Cytiva Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 8.11.4 Cytiva Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  66. 8.11.5 Cytiva Recent Developments
  67. 8.12 Croda International
  68. 8.12.1 Croda International Company Information
  69. 8.12.2 Croda International Business Overview
  70. 8.12.3 Croda International Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 8.12.4 Croda International Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  72. 8.12.5 Croda International Recent Developments
  73. 8.13 Creative Biolabs
  74. 8.13.1 Creative Biolabs Company Information
  75. 8.13.2 Creative Biolabs Business Overview
  76. 8.13.3 Creative Biolabs Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 8.13.4 Creative Biolabs Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  78. 8.13.5 Creative Biolabs Recent Developments
  79. 8.14 Corden Pharma
  80. 8.14.1 Corden Pharma Company Information
  81. 8.14.2 Corden Pharma Business Overview
  82. 8.14.3 Corden Pharma Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 8.14.4 Corden Pharma Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  84. 8.14.5 Corden Pharma Recent Developments
  85. 8.15 Catalent
  86. 8.15.1 Catalent Company Information
  87. 8.15.2 Catalent Business Overview
  88. 8.15.3 Catalent Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 8.15.4 Catalent Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  90. 8.15.5 Catalent Recent Developments
  91. 8.16 Acuitas Therapeutics
  92. 8.16.1 Acuitas Therapeutics Company Information
  93. 8.16.2 Acuitas Therapeutics Business Overview
  94. 8.16.3 Acuitas Therapeutics Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 8.16.4 Acuitas Therapeutics Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Product Portfolio
  96. 8.16.5 Acuitas Therapeutics Recent Developments
9 North America
  1. 9.1 North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Type
  2. 9.1.1 North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Type (2021-2032)
  3. 9.1.2 North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2021-2032)
  4. 9.1.3 North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Price by Type (2021-2032)
  5. 9.2 North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Application
  6. 9.2.1 North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Application (2021-2032)
  7. 9.2.2 North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2021-2032)
  8. 9.2.3 North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Price by Application (2021-2032)
  9. 9.3 North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Country
  10. 9.3.1 North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Type
  2. 10.1.1 Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Type (2021-2032)
  3. 10.1.2 Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2021-2032)
  4. 10.1.3 Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Price by Type (2021-2032)
  5. 10.2 Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Application
  6. 10.2.1 Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Application (2021-2032)
  7. 10.2.2 Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2021-2032)
  8. 10.2.3 Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Price by Application (2021-2032)
  9. 10.3 Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Country
  10. 10.3.1 Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Type
  2. 11.1.1 China Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Type (2021-2032)
  3. 11.1.2 China Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2021-2032)
  4. 11.1.3 China Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Price by Type (2021-2032)
  5. 11.2 China Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Application
  6. 11.2.1 China Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Application (2021-2032)
  7. 11.2.2 China Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2021-2032)
  8. 11.2.3 China Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Type
  2. 12.1.1 Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Type (2021-2032)
  3. 12.1.2 Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2021-2032)
  4. 12.1.3 Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Price by Type (2021-2032)
  5. 12.2 Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Application
  6. 12.2.1 Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Application (2021-2032)
  7. 12.2.2 Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2021-2032)
  8. 12.2.3 Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Price by Application (2021-2032)
  9. 12.3 Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Country
  10. 12.3.1 Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Type
  2. 13.1.1 SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Price by Type (2021-2032)
  5. 13.2 SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Application
  6. 13.2.1 SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Price by Application (2021-2032)
  9. 13.3 SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Market Size by Country
  10. 13.3.1 SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Value Chain Analysis
  2. 14.1.1 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Production Mode & Process
  6. 14.2 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Distributors
  9. 14.2.3 Liposomes and Lipid Nanoparticles Pharmaceutical Reagents Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst